Related Experiment Video
Updated: May 31, 2026

Optimizing Tubulin Yield from Porcine Brain Tissue
Published on: October 11, 2024
Tau inhibits tubulin oligomerization induced by prion protein
Katarzyna M Osiecka1, Hanna Nieznanska, Krzysztof J Skowronek
1Department of Biochemistry, Nencki Institute of Experimental Biology, Warsaw, Poland.
Abstract:
In previous studies we have demonstrated that prion protein (PrP) interacts with tubulin and disrupts microtubular cytoskeleton by inducing tubulin oligomerization. These observations may explain the molecular mechanism of toxicity of cytoplasmic PrP in transmissible spongiform encephalopathies (TSEs). Here, we check whether microtubule associated proteins (MAPs) that regulate microtubule stability, influence the PrP-induced oligomerization of tubulin. We show that tubulin preparations depleted of MAPs are more prone to oligomerization by PrP than those containing traces of MAPs. Tau protein, a major neuronal member of the MAPs family, reduces the effect of PrP. Importantly, phosphorylation of Tau abolishes its ability to affect the PrP-induced oligomerization of tubulin. We propose that the binding of Tau stabilizes tubulin in a conformation less susceptible to oligomerization by PrP. Since elevated phosphorylation of Tau leading to a loss of its function is observed in Alzheimer disease and related tauopathies, our results point at a possible molecular link between these neurodegenerative disorders and TSEs.
Insights
Microtubule-associated proteins (MAPs), like Tau, protect against prion protein (PrP)-induced tubulin damage. Tau phosphorylation impairs this protective effect, suggesting a link between transmissible spongiform encephalopathies and tauopathies.
Area of Science:
- Neurobiology
- Molecular Biology
- Prion Disease Research
Background:
- Prion protein (PrP) interacts with tubulin, disrupting the microtubular cytoskeleton via tubulin oligomerization.
- This interaction may underlie the toxicity of cytoplasmic PrP in transmissible spongiform encephalopathies (TSEs).
Purpose of the Study:
- To investigate the role of microtubule-associated proteins (MAPs) in modulating PrP-induced tubulin oligomerization.
- To determine if Tau protein, a key MAP, influences PrP's effect on tubulin.
Main Methods:
- Comparison of PrP-induced tubulin oligomerization in MAP-depleted versus MAP-containing tubulin preparations.
- Assessment of Tau protein's effect on PrP-induced tubulin oligomerization.
- Evaluation of the impact of Tau phosphorylation on its interaction with PrP and tubulin.
Main Results:
- Tubulin preparations lacking MAPs were more susceptible to PrP-induced oligomerization.
- Tau protein significantly reduced the oligomerization effect of PrP on tubulin.
- Phosphorylation of Tau abolished its protective function against PrP-induced tubulin oligomerization.
Conclusions:
- Tau protein binding stabilizes tubulin, making it less prone to PrP-induced oligomerization.
- Altered Tau phosphorylation, common in Alzheimer disease and tauopathies, may compromise this protective mechanism.
- Findings suggest a potential molecular link between TSEs and tauopathies, involving PrP and Tau interactions.
Related Concept Videos
Drugs that Stabilize Microtubules
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Destabilization of Microtubules
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Tetanus

